Related Experiment Video
Updated: Jul 10, 2026

Mapping Hepatic Stellate Cell Morphology in Mouse Models of Liver Fibrosis
Published on: February 13, 2026
Comparative studies on expression of alpha-smooth muscle actin in hepatic stellate cells in chronic hepatitis B and C
Chia-Ming Chu1, Wei-Chue Shyu, Yun-Fan Liaw
1Liver Research Unit, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taipei, Taiwan. chiamingchu@yahoo.com.tw
Insights
Hepatitis C patients show higher alpha-smooth muscle actin (alpha-SMA) expression in hepatic stellate cells (HSCs) compared to Hepatitis B patients. This HSC activation marker correlates with liver fibrosis and inflammation in both chronic viral hepatitis types.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Chronic hepatitis B and C are leading causes of liver fibrosis and cirrhosis.
- Hepatic stellate cells (HSCs) play a crucial role in liver fibrogenesis.
- Alpha-smooth muscle actin (alpha-SMA) is a key marker for HSC activation.
Purpose of the Study:
- To comparatively analyze alpha-SMA expression in HSCs between patients with chronic hepatitis B and hepatitis C.
- To investigate the correlation between HSC activation and clinicopathological factors in chronic viral hepatitis.
Main Methods:
- Immunohistochemistry and semi-quantitative scoring were used to assess alpha-SMA expression in HSCs.
- Study included 50 patients with chronic hepatitis B and 50 with chronic hepatitis C.
- HSC activation index was correlated with various clinical, biochemical, and histological parameters.
Main Results:
- HSC activation index significantly correlated with necroinflammation and fibrosis in both hepatitis B and C.
- Hepatitis C patients exhibited a significantly higher HSC activation index than hepatitis B patients.
- HSC activation also correlated with hepatic steatosis and viral load in hepatitis C.
Conclusions:
- HSC activation index is a significant independent predictor of necroinflammation and fibrosis in chronic viral hepatitis.
- Elevated HSC activation in hepatitis C suggests a potential direct role of the hepatitis C virus in HSC activation.
- Findings highlight differences in HSC activation between hepatitis B and C, impacting disease progression.
Background/Aims:
Chronic hepatitis B and hepatitis C are common causes of liver fibrosis and cirrhosis. We performed a comparative study on the expression of alpha-smooth muscle actin (alpha-SMA) in hepatic stellate cells (HSCs), a marker of HSC activation, in patients with chronic hepatitis B and hepatitis C.
Patients And Methods:
Using immunohistochemistry and a semi-quantitative scoring method, the expression of alpha-SMA in HSCs was studied in patients with chronic hepatitis B (n = 50) and hepatitis C (n = 50). The HSC activation index was correlated with age, sex, AST, ALT, viral genotype, viral titers, degrees of hepatic steatosis, necroinflammatory grades and fibrotic stages.
Results:
The HSC activation index correlated significantly (P < 0.05) with necroinflmmatory grades and fibrotic stages in chronic hepatitis B or hepatitis C. Besides, the HSC activation index also correlated significantly (P < 0.05) with hepatic steatosis and marginally significantly (P = 0.08) with serum viral titers in chronic hepatitis C. There was no significant difference in biochemical and histological activities between patients with hepatitis B and hepatitis C, but the latter had a significantly higher HSC activation index than the former. Multiple regression analysis in all 100 patients showed that the HSC activation index correlated significantly (P < 0.05) with necroinflammatory grades, fibrotic stages and hepatitis C (versus hepatitis B).
Conclusion:
In chronic viral hepatitis, the HSC activation index correlated significantly and independently with necroinflammation and fibrosis. Additionally, the HSC activation index was significantly higher in patients with chronic hepatitis C. These data may be compatible with the postulation that hepatitis C virus can directly activate HSCs.
Related Concept Videos
Hepatitis
Cirrhosis II: Pathophysiology
Cell Specific Gene Expression
Cirrhosis I: Introduction

